METAPROTERENOL

SynDRA canonical compound SYN0001791 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	ADRB2
Mechanism of action	Adrenergic receptor agonist
Indication	asthma \| bronchitis \| bronchospasm \| bronchospasm, asthma, bronchitis, emphysema \| emphysema
Disease area	pulmonary

All known targets

ADRB2

Mechanisms of action (all sources)

Adrenergic receptor agonist
ADRB2 AGONIST
Beta-2 adrenergic receptor agonist
ADRB2 MODULATOR

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)

CREB1
GLSK
PE2R2
TSHR

Drug classes

Adrenergic beta2-Agonists
Adrenergic Agents
Adrenergic Agonists
Adrenergic beta-2 Receptor Agonists
Adrenergic beta-Agonists
Anti-Asthmatic Agents
Bronchodilator Agents
Neurotransmitter Agents
Peripheral Nervous System Agents
Reproductive Control Agents
Respiratory System Agents
Sympathomimetics

ATC classes

R03A · ADRENERGICS, INHALANTS
R03C · ADRENERGICS FOR SYSTEMIC USE

Cross-references

PubChem CID: 4086
ChEMBL: CHEMBL776
DrugBank: DB00816
ChEBI: CHEBI:6792
KEGG: D00685
RxNorm: 7688
Wikipedia: Orciprenaline
TTD: D02UFG
LINCS BRD: BRD-A07780951

Synonyms

Look up METAPROTERENOL in the interactive SynDRA portal →